Anna Wong focuses her practice on intellectual property and regulatory litigation in the life sciences sector.  She represents clients in federal court, arbitral, and post-grant proceedings, and has worked on matters spanning small molecule therapeutics, antibody-drug conjugates, CAR-T therapies, LNP delivery systems, and genetic sequencing technologies. She also regularly works on drug pricing and innovation policy issues.  

Prior to joining the firm, Ms. Wong worked as a pharmaceutical policy researcher and served as a legal fellow at an international health organization. 

Insights & News

Credentials

  • Education

    • JD, University of Toronto, Faculty of Law, 2023

      Senior Board Editor, UofT Faculty of Law Review

      Massey College Junior Fellow

      International Human Rights Program Fellow

    • BSc, Molecular Genetics & Microbiology/International Relations, University of Toronto, 2020

      Honors with High Distinction
  • Admissions

    • Massachusetts

  • Languages

    • French

Credentials

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.